ILMN - イルミナ (Illumina Inc.) イルミナ

 ILMNのチャート


 ILMNの企業情報

symbol ILMN
会社名 Illumina Inc (イルミナ)
分野(sector) Capital Goods   資本財(工業製品)
産業(industry) Biotechnology: Laboratory Analytical Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 イルミナ(Illumina Inc.)は遺伝子解析用シーケンシングおよびアレイベースのソリューションを提供する。同社は2つの事業を運営する。Core Illuminaと連結変動持分事業体(VIE)事業は、GRAIL Inc. (GRAIL)とHelix Holdings I LLC (Helix)の運営を含む。Core Illuminaは核心事業を含む。その製品とサービスは、研究、臨床及び応用市場で顧客にサービスを提供し、多様なゲノムソリューションの採用を可能にする。同社の統合システム、消耗品及び分析ツールのポートフォリオは、ゲノムの複雑さ、価格ポイント、およびスループットに対応し、顧客が研究または臨床上の課題に対してソリューションを選択できるようにする。同社は、非侵襲的な出生前検査(NIPT)、着床前の遺伝的スクリーニングと診断、並びに新生児および遺伝的健康検査を含む、生殖医療ソリューションを提供している。   イルミナは、遺伝学および健康についての理解を推進する為の統合的なソリュ―ションのプロバイダ―。遺伝的変異および遺伝子機能の大規模解析を行うための包括的なライフサイエンスツ―ルとシステムの開発、製造、販売を行う。顧客は世界中のさまざまな学術機関政府機関、製薬企業、バイオテクノロジ―企業、および他の主要な機関を含む。   
本社所在地 5200 Illumina Way San Diego CA 92122 USA
代表者氏名 Jay T. Flatley ジェイ・T・フラットリー
代表者役職名 Executive Chairman of the Board 取締役会長
電話番号 +1 858-202-4500
設立年月日 35886
市場名 NASDAQ National Market System
ipoyear 2000年
従業員数 6200人
url www.illumina.com
nasdaq_url https://www.nasdaq.com/symbol/ilmn
adr_tso
EBITDA EBITDA(百万ドル) 120
終値(lastsale) 326.07
時価総額(marketcap) 47932290000
時価総額 時価総額(百万ドル) 4625.7
売上高 売上高(百万ドル) 3103
企業価値(EV) 企業価値(EV)(百万ドル) 44861.7
当期純利益 当期純利益(百万ドル) 798.00000
決算概要 決算概要 BRIEF: For the six months ended 01 July 2018 Illumina Inc. revenues increased 28% to $1.61B. Net income decreased 16% to $417M. Revenues reflect Consolidated VIEs segment increase of 100% to $6M. Basic Earnings per Share excluding Extraordinary Items decreased from $3.39 to $2.84.

 ILMNのテクニカル分析


 ILMNのニュース

   Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?  2021/04/28 18:23:39 Benzinga
Time Magazine is well-known for its annual Time100 Most Influential People issue. The media brand unveiled a new annual list called the TIME100 Most Influential Companies. The list coincides with the company’s launch of Time business, a new editorial section. Time Magazine was previously owned by Time Warner and Meredith Corporation (NYSE: MDP ) before being sold to salesforce.com, inc. (NYSE: CRM ) owner Marc Benioff. The list features five different covers featuring the CEOs of Hello Sunshine, the National Basketball Association (NBA), Gro Intelligence, General Motors Company (NYSE: GM ) and Illumina, Inc. (NASDAQ: ILMN ). Related Link: These Big Money Players Have Put Bitcoin On The Balance Sheet Here are the publicly traded companies that made the inaugural list, divided into categories by the magazine, which also provided the reason why: Pioneers Bumble Inc (NASDAQ: BMBL ): Designing a smarter, safer dating app Beyond Meat Inc (NASDAQ: BYND ): Popularizing plant-based protein Tilray Inc (NASDAQ: TLRY ): Commanding the cannabis market Roblox Corp (NYSE: RBLX ): Building a …
   Illumina Earnings, Revenue Beat in Q1  2021/04/27 21:35:18 Investing.com
https://www.investing.com/news/stock-market-news/illumina-earnings-revenue-beat-in-q1-2487318
   3 takeaways from a top Democratic senator's new book on monopolies that should have Big Pharma worried  2021/04/27 19:28:22 Business Insider
Summary List Placement Federal officials are increasing scrutiny of mergers and acquisitions in the biotech and pharma industry, and it's spooking analysts and investors. In recent months, the Federal Trade Commission has announced the creation of an international working group to review how pharmaceutical mergers, in particular, are handled. Some of the deals going through the FTC, such as Illumina's $7.1 billion purchase of Grail , have been contested as attempts to dominate a market . This increased scrutiny and other "regulatory activism" led one of Wall Street's top analysts, SVB Leerink's Geoffrey Porges, to downgrade biopharma stocks last month. Now, one of Congress' leading monopoly-busters and a recent front-runner for attorney general , Sen. Amy Klobuchar, has published a book detailing how she would combat what she sees as monopolies and other anticompetitive measures building up in the US. And the pharmaceutical industry is right in her line of sight. Klobuchar, a Minnesota Democrat, doesn't just take aim at companies acquiring one another.
   Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer Indications  2021/04/23 11:56:24 Benzinga
Illumina Inc (NASDAQ: ILMN ) and privately-held Kartos Therapeutics have announced a partnership to develop a next-generation sequencing-based TP53 companion diagnostic. The diagnostic will be based on Illumina's pan-cancer comprehensive genomic profiling assay, TruSight Oncology 500 (TSO 500), and will be used to detect TP53 mutations in multiple hematologic indications. The partnership will initially focus on developing a companion diagnostic for Kartos's … Full story available on Benzinga.com
   Dr. Gottlieb: Summer Covid risk dropping but winter could see case spike  2021/04/22 12:40:42 CNBC
Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined "Squawk Box" on Thursday to discuss what he expects when it comes to the spread of coronavirus as more businesses and employers are planning to reopen over the summer and into the fall.
   Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?  2021/04/28 18:23:39 Benzinga
Time Magazine is well-known for its annual Time100 Most Influential People issue. The media brand unveiled a new annual list called the TIME100 Most Influential Companies. The list coincides with the company’s launch of Time business, a new editorial section. Time Magazine was previously owned by Time Warner and Meredith Corporation (NYSE: MDP ) before being sold to salesforce.com, inc. (NYSE: CRM ) owner Marc Benioff. The list features five different covers featuring the CEOs of Hello Sunshine, the National Basketball Association (NBA), Gro Intelligence, General Motors Company (NYSE: GM ) and Illumina, Inc. (NASDAQ: ILMN ). Related Link: These Big Money Players Have Put Bitcoin On The Balance Sheet Here are the publicly traded companies that made the inaugural list, divided into categories by the magazine, which also provided the reason why: Pioneers Bumble Inc (NASDAQ: BMBL ): Designing a smarter, safer dating app Beyond Meat Inc (NASDAQ: BYND ): Popularizing plant-based protein Tilray Inc (NASDAQ: TLRY ): Commanding the cannabis market Roblox Corp (NYSE: RBLX ): Building a …
   Illumina Earnings, Revenue Beat in Q1  2021/04/27 21:35:18 Investing.com
https://www.investing.com/news/stock-market-news/illumina-earnings-revenue-beat-in-q1-2487318
   3 takeaways from a top Democratic senator's new book on monopolies that should have Big Pharma worried  2021/04/27 19:28:22 Business Insider
Summary List Placement Federal officials are increasing scrutiny of mergers and acquisitions in the biotech and pharma industry, and it's spooking analysts and investors. In recent months, the Federal Trade Commission has announced the creation of an international working group to review how pharmaceutical mergers, in particular, are handled. Some of the deals going through the FTC, such as Illumina's $7.1 billion purchase of Grail , have been contested as attempts to dominate a market . This increased scrutiny and other "regulatory activism" led one of Wall Street's top analysts, SVB Leerink's Geoffrey Porges, to downgrade biopharma stocks last month. Now, one of Congress' leading monopoly-busters and a recent front-runner for attorney general , Sen. Amy Klobuchar, has published a book detailing how she would combat what she sees as monopolies and other anticompetitive measures building up in the US. And the pharmaceutical industry is right in her line of sight. Klobuchar, a Minnesota Democrat, doesn't just take aim at companies acquiring one another.
   Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer Indications  2021/04/23 11:56:24 Benzinga
Illumina Inc (NASDAQ: ILMN ) and privately-held Kartos Therapeutics have announced a partnership to develop a next-generation sequencing-based TP53 companion diagnostic. The diagnostic will be based on Illumina's pan-cancer comprehensive genomic profiling assay, TruSight Oncology 500 (TSO 500), and will be used to detect TP53 mutations in multiple hematologic indications. The partnership will initially focus on developing a companion diagnostic for Kartos's … Full story available on Benzinga.com
   Dr. Gottlieb: Summer Covid risk dropping but winter could see case spike  2021/04/22 12:40:42 CNBC
Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined "Squawk Box" on Thursday to discuss what he expects when it comes to the spread of coronavirus as more businesses and employers are planning to reopen over the summer and into the fall.
   'Halftime Report' Final Trades: Illumina, Rackspace Technology And More  2021/03/19 17:10:26 Benzinga
On CNBC's "Fast Money Halftime Report," the investment committee gave their final trades of the day. Chevy Chase Trust's Amy Raskin likes Illumina, Inc. (NASDAQ: ILMN ). Market … Full story available on Benzinga.com
   Illumina Announces Board Changes  2021/03/18 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--Illumina announced that John W. Thompson will be appointed as the Company’s new Chair of the Board following Jay Flatley's decision to step down.
   Genomics in Cancer Care Market to Grow with a High CAGR- Global Industry Analysis, Key Manufacturers Illumina Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc  2021/03/18 17:00:12 OpenPR
The insight Partners Research has recently added a concise research on the Global Genomics in Cancer Care Market – Industry Trends and Forecast to 2027. A reliable Global Genomics in Cancer Care Market report contains market data that can be
   Hemato Oncology Testing Market Overview by Increasing Demands and Sales 2021 to 2027 |Abbott Laboratories, Qiagen N.V., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc  2021/03/15 16:46:46 OpenPR
Hemato Oncology Testing Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and
   Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women  2021/03/11 21:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--A new study shows that the cost of offering NIPT in all pregnancies is minimal whereas this screening method is known to produce better outcomes

 関連キーワード  (先端医療機器_テクノロジ― 米国株 イルミナ ILMN Illumina Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)